GeoVax Labs (GOVX) vs Mustang Bio (MBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Mustang Bio is the larger company by market cap ($3.2 million vs $2.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | GOVX | MBIO |
|---|---|---|
| Share price | $0.2866 | $0.417 |
| Market cap | $2.90M | $3.16M |
| 1-day change | -0.97% | -7.37% |
| EPS (TTM) | $-8.84 | $-0.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.75 | $1.85 |
| 52-week low | $0.277 | $0.4101 |
| Distance from 52-week high | -98.18% | -77.46% |
| Average volume | 769.87K | 29.24K |
| Shares outstanding | 10.10M | 6.73M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GOVX vs MBIO FAQ
Which is bigger, GeoVax Labs or Mustang Bio?
Mustang Bio (MBIO) is larger, with a market capitalization of $3.16M compared with $2.90M for GeoVax Labs (GOVX).
Are GeoVax Labs and Mustang Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.